Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2008 Jul;29(7):981-91.
doi: 10.1016/j.neurobiolaging.2007.01.012. Epub 2007 Mar 9.

Altered medial temporal lobe responses during visuospatial encoding in healthy APOE*4 carriers

Affiliations

Altered medial temporal lobe responses during visuospatial encoding in healthy APOE*4 carriers

Paul R Borghesani et al. Neurobiol Aging. 2008 Jul.

Abstract

The apolipoprotein varepsilon4 allele (APOE*4) is a major genetic risk factor for Alzheimer's disease (AD) and has been associated with altered cortical activation as assessed by functional neuroimaging in cognitively normal younger and older carriers. We chose to evaluate medial temporal lobe (MTL) activation during encoding and recognition using a perspective-dependent (route or survey) visuospatial memory task by monitoring the blood-oxygen-level-dependent (BOLD) fMRI response in older, non-demented APOE*4 carriers (APOE*4+) and non-carriers (APOE*4-). During encoding, the APOE*4- group had greater average task-associated BOLD responses in ventral visual pathways, including the MTLs, as compared to the APOE*4+ group. Furthermore, MTL activation was greater during route encoding than survey encoding on average in APOE*4-, but not APOE*4+, subjects. During recognition, both groups performed similarly and no BOLD signal differences were found. Finally, within-group analysis revealed MTL activation during encoding was correlated with recognition performance in APOE*4-, but not APOE*4+ subjects. Reduced task-associated MTL activation that does not correlate with either visuospatial perspective or task performance suggests that MTL dysregulation occurs prior to clinical symptoms of dementia in APOE*4 carriers.

PubMed Disclaimer

Conflict of interest statement

Disclosure statement

There are no actual or potential conflicts of interest for the authors that could have inappropriately influenced this work. Subjects were recruited in accordance with the University of Washington Internal Review Board (IRB) approved policies and procedures.

Figures

Figure 1
Figure 1
Cortical activation during route and survey encoding contrasted with fixation. (a) APOE*4− subjects displayed robust activation of MTLs, ventral occipital regons areas and prefrontal cortex (not shown) during both route (upper) and survey (lower) encoding. (b) APOE*4+ subjects had less overall task associated activation during encoding which statistically was limited to the fusiform gyrus during route (upper) and survey (lower) encoding. An area of deactivation (blue) in the temporal/parietal regions was evident during survey encoding. Within-group contrasts with z-threshold = 2.7 and p < 0.01 (n=7 per group).
Figure 2
Figure 2
Regions of greater activation in APOE*4− than APOE*4+ subjects during encoding. (a) Regions where APOE*4− subjects had greater BOLD signal during either route or survey encoding include the posterior (left) and anterior (right) MTLs and areas around the occipital-temporal-parietal junction. Between-group contrasts with z-threshold = 2.5 and p < 0.01 (n=14). (b) Average z-scores for individual subjects in the MTLroi during route (filled symbols:●,■) and survey (open symbols: ○, □) encoding. APOE*4− subjects (■, □) and APOE*4+ subjects (●, ○).
Figure 3
Figure 3
Route/survey activation differential in APOE*4− subjects. (a) Regions of greater activation during route than survey encoding in APOE*4− subjects include the MTLs bilaterally, the left frontal and the right parietal cortex. Within-group contrasts with z-threshold = 2.5 and p < 0.01 (n=7). (b) Average route/survey differential z-scores in individual subjects within the MTLroi. APOE*4− subjects (■) and APOE*4+ subjects (○).
Figure 4
Figure 4
Performance correlated activation in the MTLs during encoding. (a) Areas where there is a genotype x performance interaction in the left (p=0.01) and posterior right (p=0.08) MTLs during route encoding. Z-threshold = 2.3. (b) Average z-scores within these areas (combined) during route encoding correlate with performance in APOE*4− but not APOE*4+ subjects. APOE*4− subjects (■) and APOE*4+ subjects (○).

References

    1. Bassett SS, Yousem DM, Cristinzio C, Kusevic I, Yassa MA, Caffo BS, Zeger SL. Familial risk for Alzheimer’s disease alters fMRI activation patterns. Brain. 2006;129 (Pt 5):1229–39. - PMC - PubMed
    1. Bondi MW, Houston WS, Eyler LT, Brown GG. fMRI evidence of compensatory mechanisms in older adults at genetic risk for Alzheimer disease. Neurology. 2005;64 (3):501–8. - PMC - PubMed
    1. Bookheimer SY, Strojwas MH, Cohen MS, Saunders AM, Pericak-Vance MA, Mazziotta JC, Small GW. Patterns of brain activation in people at risk for Alzheimer’s disease. N Engl J Med. 2000;343 (7):450–6. - PMC - PubMed
    1. Braak H, Braak E. Diagnostic criteria for neuropathologic assessment of Alzheimer’s disease. Neurobiol Aging. 1997;18 (4 Suppl):S85–8. - PubMed
    1. Burgess N, Becker S, King JA, O’Keefe J. Memory for events and their spatial context: models and experiments. Philos Trans R Soc Lond B Biol Sci. 2001;356 (1413):1493–503. - PMC - PubMed

Publication types

Substances